Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?
Journal of Thoracic Disease and Cardiothoracic Surgery · 2020
DOI: 10.31579/2693-2156/002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thoracic Disease and Cardiothoracic Surgery, 2020. Verfasst von Gary L. Murray.
Abstract (Originalsprache)
The Society of Thoracic Surgery Score and Euro II Score are tools for estimating major adverse cardiac events (MACE [death {or morbidity}, renal failure, stroke, prolonged ventilation, CSW infection, reoperation, prolonged admission]) after cardiac surgery.
Zitieren
APA
Murray, G. L. (2020). Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?. Journal of Thoracic Disease and Cardiothoracic Surgery. https://doi.org/10.31579/2693-2156/002
Vancouver
Murray GL. Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?. Journal of Thoracic Disease and Cardiothoracic Surgery. 2020. doi:10.31579/2693-2156/002
BibTeX
@article{Murray2020,
author = {Murray, Gary L.},
title = {Cardiac Perioperative MACE: Could Ranolazine Safely Reduce it >35%?},
journal = {Journal of Thoracic Disease and Cardiothoracic Surgery},
year = {2020},
doi = {10.31579/2693-2156/002}
}
EUVIMED